Navigation Links
Pharmaceutical Partnership Deal Terminations
Date:9/7/2011

icensing Agreement with Ipsen for Taspoglutide 87

4.16.1 Companies Overview 88

4.16.2 Product Overview 88

4.16.3 Deal Overview 95

4.16.4 Reason for Termination 95

4.17 Roche Terminates Licensing Agreement with Transgene for Papilloma Vaccine TG4001 96

4.17.1 Companies Overview 96

4.17.2 Product Overview 97

4.17.3 Deal Overview 97

4.17.4 Reason for Termination 98

4.18 Rigel Pharmaceuticals Terminates Licensing Agreement with Pfizer for R343 98

4.18.1 Companies Overview 99

4.18.2 Product Overview 100

4.18.3 Deal Overview 100

4.18.4 Reason for Termination 100

4.19 Abbott Laboratories Terminates Licensing Agreement with SkyePharma for Flutiform 101

4.19.1 Companies Overview 102

4.19.2 Product Overview 103

4.19.3 Deal Overview 108

4.19.4 Reason for Termination 108

4.20 Merck Terminates Strategic Alliance with Intercell for V710 109

4.20.1 Companies Overview 109

4.20.2 Product Overview 110

4.20.3 Deal Overview 114

4.20.4 Reason for Termination 114

5 Top Partnership Deal Terminations - Appendix 115

5.1 Market Definitions 115

5.2 Abbreviations 115

5.3 Research Methodology 117

5.3.1 Coverage 117

5.3.2 Secondary Research 118

5.3.3 Primary Research 118

5.3.4 Section-wise Research Methodology 118

5.3.5 Expert Panel Validation 119

5.4 Contact Us 119

5.5 Disclaimer 119

5.6 Sources 119

1.1 List of Tables

Table 1: Top Partnership Deal Terminations, Reasons for Deal Terminations, 2010-2011 12

Table 2: Top Partnership Deal Terminations, Therapeutic Areas, 2010-2011 13

Table 3: Top Partnership Deal Terminations, Comparative Analysis of Reasons for Deal Terminations for Various Therapeutic Areas, 2010-2011 14

Table 4: Top Partnership Deal Terminations, Comparative Analysis of Deal Values of the To
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. MAP Pharmaceuticals to Present at Upcoming Investor Conferences
2. Webcast Alert: Isis Pharmaceuticals Hosts Dr. John Kastelein to Review Mipomersen Long-term Data Recently Presented at ESC Congress 2011
3. Omthera Pharmaceuticals, Inc. to Present at the Rodman and Renshaw 13th Annual Healthcare Conference
4. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
5. Access Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference on Monday, September 12th in New York City
6. ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference on September 12
7. Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force
8. Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets
9. Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity
10. Lexicon Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
11. Pacira Pharmaceuticals, Inc. Expands EXPAREL™ Commercial Team Infrastructure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Calif. , May 20, 2013 Sequent ... mark for the SL ("Single Layer") family of WEB ... controlled release of these new models in select neurovascular ... profile and superior navigability that will enable physicians to ... platform. The SL configurations are made possible ...
(Date:5/20/2013)... ATLANTA , May 20, 2013  Atlantic ... developed and is commercializing a unique technology to ... founder and President, Anthony Soscia ... the Atlanta Business Chronicle ,s Health-Care Heroes ... Atlanta Business Chronicle to honor individuals and ...
(Date:5/20/2013)... , May 20, 2013 Enrollment of ... Therapeutics, Phase 2b dose-finding clinical trial of product candidate ... the foundational treatment for Type 2 diabetes. Elcelyx expects ... U.S. program in June. Results of the trial,s primary ... in late summer, and the read-out for long-term glucose ...
Breaking Medicine Technology:Sequent Medical, Inc. Launches New SL Family of WEB Aneurysm Embolization Devices 2Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 4
... MONMOUTH JUNCTION, N.J., Sept. 11 Signum Biosciences, Inc has ... Phase II grant by the National Institute of Allergy and ... STM (Signal Transduction Modulator) anti-inflammatory technology for the treatment of ... 2008, NIH/NIAID awarded Signum a SBIR Phase I grant to ...
... , , ROCHESTER, Minn., Sept. 11 ... mice were associated with good central nervous system repair in multiple ... effective therapies for patients with MS and for predicting MS patients, ... European Committee for Treatment and Research in Multiple Sclerosis in Dusseldorf, ...
Cached Medicine Technology:Signum Biosciences Awarded Phase II SBIR Grant by the NIH for the Treatment of Rosacea 2Researchers Identify Two Genes as Potential Therapeutic Targets for Multiple Sclerosis 2Researchers Identify Two Genes as Potential Therapeutic Targets for Multiple Sclerosis 3
(Date:5/21/2013)... The National Resident Matching Program NRMP® ... its Board of Directors. Hal B. Jenson, M.D., ... of Medicine, has been named President. Maria C. ... of California San Diego, is the President-Designate, and Glenn ... Medical Center, is the Secretary-Treasurer. Kenneth B. Simons, ...
(Date:5/21/2013)... Dr. James C. Wittig, Chief of ... Sarcoma Division of the John Theurer Cancer Center at ... named one of the top 13 Orthopedic Oncologists in ... Wittig is one of approximately 125 surgeons in America ... by surveying thought leaders in the field of Oncology. ...
(Date:5/21/2013)... 21, 2013 Brunswick Laboratories, Inc. ... the development and standardization of validated analytical methods, ... Brunswick Laboratories and the USDA, as a First ... This decision comes after extensive review by an ... Harnly of the U.S. Department of Agriculture. , ...
(Date:5/21/2013)... According to the Center for Disease Control and ... year. Over 800,000 of these bites require medical attention, ... should be aware of the danger that dog bites pose ... and children may sustain more serious injuries than an adult. ... the ages of 5 and 9 are at the greatest ...
(Date:5/20/2013)... USA Book News announced Monday that "The ... won the top honor in its 2013 International Book ... multitude of international titles published from 2011-2013, "The Infinity ... both mainstream and new age audiences looking to improve ... , “The Infinity Zone” is a phenomenon ...
Breaking Medicine News(10 mins):Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 2Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 3Health News:James C. Wittig, MD, Selected as one of America's Top 13 Orthopaedic Oncologists 2Health News:James C. Wittig, MD, Selected as one of America's Top 13 Orthopaedic Oncologists 3Health News:AOAC International Approves ORAC as First Action Official Method 2Health News:Personal Injury Law Firm Announces New Informational Graphic Regarding Dog Bite Injuries 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 3
... 19 PAREXEL International Corporation (Nasdaq: PRXL ) ... Monday, January 26, 2009 after the close of the stock ... at www.parexel.com and on the PR Newswire website ... live webcast at 10:00 a.m. ET on Tuesday, January 27, ...
... a free prostate cancer screening and educational information on Monday 1/19 ... providing Atlanta residents with information about prostate health, the Prostate Proactivity ... (RCOG) and NewsTalk 750 WSB. , ... Atlanta, GA ...
... A collection of hospitals in eight cities around the ... surgical checklist during major operations can lower the incidence of ... study was led by researchers from the Harvard School of ... and the results are published Online First on Wednesday, January ...
... Believe in Khanna LASIK and change (improve) vision especially if you ... ... 18, 2009 -- In honor of the Presidential Inauguration on Tuesday, ... free LASIK surgery to any US citizen named "Barack Hussein Obama". ...
... Takes only minutes when temperatures drop to cause permanent damage, ... -- When the weather outside is frigid, do you know ... minutes for exposed skin to become frostbitten if the temperature ... at 20 miles per hour or more," Dr. Taizoon Baxamusa, ...
... the HIMSS Analytics Database, 85 percent of hospitals in the contracting phase ... since November 2007, when CCHIT released its first acute care or inpatient ... ... data from the HIMSS Analytics Database, 85 percent of hospitals in the ...
Cached Medicine News:Health News:PAREXEL Announces Date of Second Quarter Fiscal Year 2009 Earnings Release and Conference Call 2Health News:Radiotherapy Clinics of Georgia and NewsTalk 750 WSB Team Up to Promote Prostate Proactivity 2Health News:Radiotherapy Clinics of Georgia and NewsTalk 750 WSB Team Up to Promote Prostate Proactivity 3Health News:Hospitals demonstrate surgical safety checklist drops deaths and complications by more than a third 2Health News:Hospitals demonstrate surgical safety checklist drops deaths and complications by more than a third 3Health News:Hospitals demonstrate surgical safety checklist drops deaths and complications by more than a third 4Health News:LASIK Surgery for "Barack Hussein Obama" 2Health News:Hard, Cold Facts About Frostbite 2Health News:85 Percent of Hospitals Select CCHIT Certified Products 2Health News:85 Percent of Hospitals Select CCHIT Certified Products 3Health News:85 Percent of Hospitals Select CCHIT Certified Products 4Health News:85 Percent of Hospitals Select CCHIT Certified Products 5
SofLens Multi-Focal with unique Natra-Sight Optics designed to provide broad transition for near, intermediate and far vision, SofLens Multi-Focal lenses offer crisp, clear vision at all distances....
An easy-to-fit high water content spherical soft lens manufactured using cast molding technology, and designed for use in the correction of myopia on a daily wear or extended wear basis....
Bausch & Lomb SofLens59 contact lenses combine excellent performance, comfort and visual acuity providing daily wear for two week replacement....
... uses reflection mirrors to measure the ... after tumor removal or thyroid decompression. ... Naugle is easy to handle- with ... and plastic mounts that are placed ...
Medicine Products: